http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-98347-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16b8f6060f27891fbf90451241b42338
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_589c8df6b893cc5535b64223908273d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c60d3bb097cf7066e37d790e98ccf6fd
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
filingDate 2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1bc8c3bc1403dd197b48b6c2567b32f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0f5086d0a5904c9ad27016498060219
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad6349ada458cb6cbd8ac70f49cd79e5
publicationDate 2015-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-98347-U
titleOfInvention METHOD FOR PREVENTION OF NON-CARE OF PREGNANCY IN WOMEN WITH THE PRESENCE OF MALE AND FEMALE INFERTILITY FACTOR AFTER EXTRACORPORAL FERTILIZATION BY THE METHOD OF INTRACYTOPLASMATIC INJECULATOR INJECTS
abstract Method for the prevention of pregnancy miscarriage in women with the presence of male and female factor of infertility after extracorporeal fertilization by intracytoplasmic injection of spermatozoa into oocytes, and the woman is administered micronized to the extracorporeal fertilization with the use of intracranial fertilization and weeks of pregnancy, and immunoglobulin Bioven 200 ml I / O every 4 weeks before implantation 1-3 weeks and after implantation up to 12 weeks of pregnancy.
priorityDate 2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553937

Total number of triples: 16.